High burden of viruses and bacterial pathobionts drives heightened nasal innate immunity in children with and without SARS-CoV-2
Watkins, T. A.; Cheemarla, N. R.; Hansel, K.; Green, A. B.; Amat, J. A. R.; Lozano, R.; Dudgeon, S. N.; Landry, M. L.; Schulz, W. L.; Foxman, E. F.
Show abstract
Recent work indicates that heightened nasal innate immunity in children may impact SARS-CoV-2 pathogenesis. Here, we identified drivers of nasal innate immune activation in children using cytokine profiling and multiplex pathogen detection in 291 pediatric nasopharyngeal samples from the 2022 Omicron surge. Nasal viruses and bacterial pathobionts were highly prevalent, especially in younger children (81% of symptomatic and 37% asymptomatic children overall; 91% and 62% in subjects <5 yrs). For SARS-CoV-2, viral load was highest in young children, and viral load in single infections or combined viral loads in coinfections best predicted nasal CXCL10, a biomarker of the mucosal interferon response. Bacterial pathobionts correlated with high nasal IL-1{beta} and TNF, but not CXCL10, and viral-bacterial coinfections showed a combined immunophenotype. These findings reveal virus and bacteria as drivers of heightened nasal innate immunity in children and suggest that frequent host-pathogen interactions shape responses to respiratory viruses in this age group.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Natural Mucosal Barriers and COVID-19 in Children 96%
- Asymptomatic or mild symptomatic SARS-CoV-2 infection elicits durable neutralizing antibody responses in children and adolescents 95%
- Airway antibodies emerge according to COVID-19 severity and wane rapidly but reappear after SARS-CoV-2 vaccination 94%
Similar papers in this journal
- Elevated mucosal antibody responses against SARS-CoV-2 are correlated with lower viral load and faster decrease in systemic COVID-19 symptoms 96%
- Type 2 and interferon inflammation strongly regulate SARS-CoV-2 related gene expression in the airway epithelium 96%
- Delayed induction of type I and III interferons mediates nasal epithelial cell permissiveness to SARS-CoV-2 95%
Similar papers in this journal
- Rapid emergence of SARS-CoV-2 Omicron variant is associated with an infection advantage over Delta in vaccinated persons 92%
- Immunogenicity of convalescent and vaccinated sera against clinical isolates of ancestral SARS-CoV-2, beta, delta, and omicron variants 92%
- Omicron neutralizing antibody response following booster vaccination compared with breakthrough infection 91%
Similar papers in this journal
- Pathogenic and transcriptomic differences of emerging SARS-CoV-2 variants in the Syrian golden hamster model 93%
- Anti-SARS-CoV-2 Antibodies Persist for up to 13 Months and Reduce Risk of Reinfection 93%
- The COVID-19 Pandemic as an Opportunity for Unravelling the Causative Association between Respiratory Viruses and Pneumococcus-Associated Disease in Young Children: A Prospective Study 93%
Similar papers in this journal
- Infectious viral shedding of SARS-CoV-2 Delta following vaccination: a longitudinal cohort study 95%
- Fibroblast growth factor-9 expression in airway epithelial cells amplifies the type I interferon response and alters influenza A virus pathogenesis 94%
- Type I and III IFNs produced by the nasal epithelia and dimmed inflammation are key features of alpacas resolving MERS-CoV infection 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.